Preterminal protein, the achilles heel of adenoviridae: Implications for adenoviral infections

doi:10.5497/wjp.v13.i2.97723

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (969)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

HTML

404

Figures (1-7)

129

Sum=554

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

203

Sum=295

Publishing Process of This Article

Item

Count

Browse

Download

Sum=101

Nov 29, 2024 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Pharmacol. Nov 29, 2024; 13(2): 97723
Published online Nov 29, 2024. doi: 10.5497/wjp.v13.i2.97723

Full Size Figure Download Figure

Figure 3 MALDI-TOFF MS of unbound preterminal protein. Inset (A) shows a 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis chromatogram of pooled unbound and bound preterminal protein (1:1). Preterminal protein (30 µg) appears at 76.283 kDa.

Citation: Walsh HA. Preterminal protein, the achilles heel of adenoviridae: Implications for adenoviral infections. World J Pharmacol 2024; 13(2): 97723
URL: https://www.wjgnet.com/2220-3192/full/v13/i2/97723.htm
DOI: https://dx.doi.org/10.5497/wjp.v13.i2.97723